Dr. Balasubramaniam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10903 New Hampshire Ave
Silver Spring, MD 20993Phone+1 240-402-4975
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2006 - 2011
- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2003 - 2006
- SSM Health/Saint Louis University School of MedicineResidency, Surgery, 1998 - 2002
- SUNY Upstate Medical UniversityClass of 1998
Certifications & Licensure
- DC State Medical License 2003 - 2022
Publications & Presentations
PubMed
- 13 citationsPhase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid CancerJaydira Del Rivero, Maureen Edgerly, Jean Ward, Ravi A. Madan, Sanjeeve Balasubramaniam
The Oncologist. 2019-01-01 - 101 citationsFDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer.Shaily Arora, Sanjeeve Balasubramaniam, Hui Zhang, Tara Berman, Preeti Narayan
The Oncologist. 2021-01-01 - 24 citationsAdvancing Clinical Trials to Streamline Drug Development.Susan E. Bates, Donald A. Berry, Sanjeeve Balasubramaniam, Stuart Bailey, Patricia LoRusso
Clinical Cancer Research. 2015-10-15
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: